Document: Dates of 2026 Scientific Advice Working Party - Human (SAWP-H) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests

Document: Medicine shortage communication (MSC): Natpar (parathyroid hormone) (25, 50, 75 and 100 micrograms/dose powder and solvent for solution for injection)-2026/2/13

Page: Guidance on good manufacturing practice and good distribution practice: Questions and answers-2026/3/24

Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/4/28

Document: Records of data processing activity regarding EMA Account Management System (public)-2026/6/9

Document: Terms of reference for the European Medicines Agency – United States Food and Drugs Administration – Health Canada cluster on real world data-2026/7/17

关于公开征求《药物临床试验方案审评工作规范（征求意见稿）》意见的通知-2022/10/27

国家药监局关于发布化学仿制药参比制剂调整程序的公告（2023年第35号）-2023/03/24

Final Guidance: Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--“Dose Banding”-2023/9/29

Document: Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products-2025/1/7